A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia

Clinical trial NCT00559091 · COMPLETED

Trial details

NCT number: NCT00559091
Sponsor: Jewish General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myelocytic Leukemia

Start date: 2007-04-01
Primary completion: 2010-02-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.